News

PHEXCOM

Solution BY Communication

Call：+86 021-55807300

Position：Home > News >

Catalent pumps $50M into Indiana fill-finish capacity with COVID-19 vaccine contracts in hand

With a suite of drugmakers looking for manufacturing partners in the hunt for a COVID-19 vaccine, major contract manufacturers are stepping in to help handle the load. One of those, New Jersey's Cata
2020/9/4
Amping up its sustainability goals, Novartis targets carbon neutrality across supply chain by 2030

In the past year or so, Novartis has focused on better governance by tightening its ethics standards. Now the Swiss pharma is also working to improveits corporate image from an environmental perspect
2020/9/3
Trump's touting a drug pricing meeting with execs, but PhRMA's 'not aware' of it

With two months until the election, President Donald Trump has made numerouspledges about drug pricing over the past few weeks. But his latestclaim ofameeting set between the White House and drug exe
2020/9/3
Rebuking FDA, NIH experts say 'no data' support plasma as a COVID-19 treatment

A deadly pandemic isn't thetime for leading U.S. health agencies to disagree on data and treatment benefits, but that's the situation playing out as new COVID-19treatment guidelinesfrom the National
2020/9/1
U.S. Army taps Florida CDMO Ology with $106M work order for COVID-19 shots, therapeutics

With a suite of COVID-19 vaccines and therapeutics ontheir way to market, the U.S. government has been working to secure enough manufacturing capacity to meet demand. Now, the Army will pay big money
2020/8/28
Regeneron plots 400 hires to handle increased workload amid COVID-19 cocktail production push

Regeneron and Swiss drugmaker Roche made waves earlier this month with a gargantuan manufacturing pact to triple production of a hopeful COVID-19 antibody cocktail. But those big plans put a crunch o
2020/8/28
Cassiopea scores FDA approval for Winlevi, the first novel acne med in decades

It’s been decades since a novel acne treatment hit the scene,but that’s set to change with Cassiopea’s approval forWinlevi. The FDA onThursdayapprovedthe new prescription acne medication, set for use
2020/8/27
FDA puts India's Wintac on blast for lackadaisical probe into bacterial contamination

When FDA investigators identify potentially grave issues at a drug manufacturer's facility, the general assumption is that the company will do its best to remedy the problem. But few things rileup th
2020/8/27
Teva indicted on U.S. price-fixing charges after walking away from settlement offers

With the walls closing in around it on a yearslong generics price-fixing probe, Israeli drugmaker Teva faced two options: Reach a deal with prosecutors or gamble. Teva chose to roll the dice, and now
2020/8/26
Upset with Trump's international pricing index, PhRMA submits a counteroffer: Politico

After a harsh initial reaction to President Donald Trump's order tyingU.S. drug prices to the much lower stickers abroad, pharma companies have come to the negotiating table. In a counteroffer sent t
2020/8/26

Excipients